A Randomized, Partially-blinded, Placebo-controlled, Two-way Crossover, Proof of Concept Study to Compare the Relative Efficacy of CRTh2 Receptor Antagonist, QAV680 Against Placebo in the Treatment of Allergic Rhinitis in an Environmental Exposure Chamber (EEC) Model

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This study will compare the effectiveness of QAV680 against placebo in treating the symptoms of seasonal allergic rhinitis in an Environmental Exposure Chamber.
Epistemonikos ID: 2de5b795c05435891e47356f049fefdb57e9b09e
First added on: May 05, 2024